Alesta Therapeutics is a startup based in the Netherlands, most recent round Series A, 1 tracked investor.
Alesta Therapeutics is a company founded in 2020 headquartered in the Netherlands. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Alesta Therapeutics is a biotechnology company focused on developing transformative small-molecule therapies for rare diseases. Its lead program, ALE1, is designed to treat hypophosphatasia, a rare genetic disorder, and is currently in clinical development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.